Skip to main content

Table 1 Main phenotypic characteristics of patients belonging to the Dercum’s disease and Roch Leri lipomatosis (LMS) groups

From: Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis

Characteristics at diagnosis

Dercum (n = 9)

LMS (n = 11)

p

Clinical data

Sex-ratio (M/F)

0.5 (3 M/6F)

1.75 (7 M/4F)

0.005

Age (years)

30.8 [16–50]

31.2 [18–68]

0.69

Weight (kg)

89 [58–98]

100 [55–142]

0.42

BMI (kg/m2)

32 [27–59]

31 [25–35]

0.71

Number of lipomas > 10 (%; n/N)

89% (8/9)

82% (9/11)

 > 0.9

Encapsulated—fibrotic—ecchymotic (%; n/N)

89–11–11% (9/9)

100–9–9% (11/11)

 > 0.9

History of surgery (%; n/N)

56% (7/9)

54.5% (6/11)

 > 0.9

Lipomas sites

Forearm/arm (%; n/N)

56% (5/9)

82% (9/11)

0.042

Back

56% (5/9)

27% (3/11)

0.87

Abdomen

44% (4/9)

55% (6/11)

0.99

Thigh

67% (6/7)

73% (8/11)

 > 0.99

Flank/ Lumbar fossa

44% (4/9)

36% (4/11)

 > 0.99

Legs

11% (1/9)

27% (3/11)

0.80

Other

44% (4/9)

9% (1/11)

0.048

Personal history

Treated hypertension (%; n/N)

22% (2/9)

64% (7/11)

0.33

Diabetes (%; n/N)

33% (3/9)

9% (1/11)

0.28

Treated dyslipidemia (%; n/N)

11% (1/9)

45% (5/11)

0.16

Family history

History of lipomatosis

11% (1/9)

27% (3/11)

 > 0.9

History of diabetes

55% (5/9)

9% (1/11)

 > 0.9

  1. The number of patients studied was indicated only when at least one data point was missing: n: number of examinations performed/ N: total number of patients in the group
  2. *: p < 0.05, **: p < 0.01, ***: p < 0.001, ns: non significant; p > 0.05*: p < 0.05, **: p < 0.01, ***: p < 0.001, ns: non significant